CoChat

Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke

Open access
Li, Yazhou, Wu, Kou-Jen, Yu, Seong-Jin, Tamargo, Ian A., Wang, Yun, Greig, Nigel H. · 2017 · Experimental Neurology
Cited by 33

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

ABSTRACT Proglucagon‐derived peptides, especially glucagon‐like peptide‐1 (GLP‐1) and its long‐acting mimetics, have exhibited neuroprotective effects in animal models of stroke. Several of these peptides are in clinical trials for stroke. Oxyntomodulin (OXM) is a proglucagon‐derived peptide that co‐activates the GLP‐1 receptor (GLP‐1R) and the glucagon receptor (GCGR). The neuroprotective action of OXM, however, has not been thoroughly investigated. In this study, the neuroprotective effect of OXM was first examined in human neuroblastoma (SH‐SY5Y) cells and rat primary cortical neurons. GLP‐1R and GCGR antagonists, and inhibitors of various signaling pathways were used in cell culture to characterize the mechanisms of action of OXM. To evaluate translation in vivo, OXM‐mediated neuroprotection was assessed in a 60‐min, transient middle cerebral artery occlusion (MCAo) rat model of stroke. We found that OXM dose‐ and time‐dependently increased cell viability and protected cells from glutamate toxicity and oxidative stress. These neuroprotective actions of OXM were mainly mediated through the GLP‐1R. OXM induced intracellular cAMP production and activated cAMP‐response element‐binding protein (CREB). Furthermore, inhibition of the PKA and MAPK pathways, but not inhibition of the PI3K pathway, significantly attenuated the OXM neuroprotective actions. Intracerebroventricular administration of OXM significantly reduced cerebral infarct size and improved locomotor activities in MCAo stroke rats. Therefore, we conclude that OXM is neuroprotective against ischemic brain injury. The mechanisms of action involve induction of intracellular cAMP, activation of PKA and MAPK pathways and phosphorylation of CREB. Graphical abstract Figure. No caption available. HighlightsWe evaluated the neurotrophic and neuroprotective actions of OXM in neuronal cultures and in an ischemic stroke model.OXM provided neurotrophic properties in immortal human SH‐SY5Y neuronal cells ‐ elevating cAMP levels and pCREB.OXM provided neuroprotection against glutamate excitotoxicity and oxidative stress injury in SH‐SY5Y cells and rat primary neurons.OXM actions were primarily mediated by the GLP‐1R but not GCGR, and involved the PKA and MAPK but not PI3K pathway.OXM significantly reduced cerebral infarct size and improved locomotor activities in a transient MCAo rat model of stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.expneurol.2016.11.010

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 33

Metadata

Authors
Li, Y., Wu, K.-J., Yu, S.-J., Tamargo, I. A., Wang, Y., & Greig, N. H.
Venue
Experimental Neurology
Publisher
Elsevier BV
Published
2017-02
Volume
288
Pages
104-113
ISSN
0014-4886 (ISSN-L)
OpenAlex
W2549177900
Cited by
33
References
16
FWCI
1.63
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke. https://app.cochat.ai/papers/10.1016/j.expneurol.2016.11.010
The paper
Li, Y., Wu, K.-J., Yu, S.-J., Tamargo, I. A., Wang, Y., & Greig, N. H. (2017). Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke. Experimental Neurology. https://doi.org/10.1016/j.expneurol.2016.11.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.